1. NSW TAG Pethidine in ED Project
Interim
Aggregate Results
Project Workshop August 2003
Supported by the National Institute of Clinical Studies Australia's national agency for closing the gaps between evidence and practice in health care.

2. How did we do?
Goal:
50% reduction in pethidine use with each audit cycle
Remember:
Audit Cycle 1 began Jan 03
Audit Cycle 2 began Apr 03
Audit Cycle 3 began July 03

3. Pethidine issues to ED

4. Pethidine issues to ED A = Principal referral B = Major non-teaching
C = District
D = Community
Pethidine issues to ED

5. Pethidine issues to hospital (excluding ED)

6. Pethidine issues to hospital (excluding ED)

7. Morphine issues to ED

8. Morphine issues to ED

9. Tramadol issues to ED

10. Tramadol issues to ED

11. Ketorolac issues to ED

12. Ketorolac issues to ED

13. Fentanyl issues to ED

14. Fentanyl issues to ED

15. Pethidine as a proportion of all parenteral analgesia in ED

16. Pethidine as a proportion of all parenteral analgesia in ED

17. Pethidine as a proportion of all parenteral analgesia in ED

18. Pethidine as a proportion of all parenteral analgesia in ED

19. Reduction in pethidine use: Did we achieve our goal?
Pethidine units issued to ED – All hospitals
Overall (to date): - 47%

20. Indications for pethidine use

21. Which teams are prescribing?

22. Which prescribers?